Clinical Trial Update: Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC. [Phase 2]

View source ↗

Summary

Phase II trial evaluating first-line treatment of metastatic squamous non-small cell lung cancer with cisplatin/carboplatin, polymeric micelle paclitaxel (Pm-Pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Ivonescimab (AK112/SMT112)
• Paclitaxel (Pm-Pac) — polymeric micelles formulation (paclitaxel)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Squamous Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING